TheraRadar
← Back
Data updated: May 24, 2026

SOMERSET THERAPS LLC

Generics

SOMERSET THERAPS LLC is a generic drug manufacturer focused on Infectious Disease, Neurology, Cardiovascular. Key products include POTASSIUM PHOSPHATES.

2008
Since
70
Drugs
-
Trials
1
New Drugs (2yr)
Modality:
1 Small Molecules

Key Drugs

Top revenue-generating and strategically important drugs approved in the last 15 years. These represent the company's core commercial portfolio.

Therapeutic Areas

Disease areas where this company has approved drugs and active pipeline. Weighted by commercial stage: approved drugs count most, followed by late-stage trials.

Infectious Disease 25%
6 drugs
Neurology 25%
6 drugs
Cardiovascular 25%
6 drugs
Oncology 17%
4 drugs
Immunology 8%
2 drugs

Pipeline Snapshot

Active clinical trials across all therapeutic areas. Data from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • SACUBITRIL AND VALSARTAN leads revenue
  • 2 key drugs tracked

Trial Catalysts

  • Infectious Disease pipeline focus
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling